GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Maven Brands Inc (XCNQ:MJ) » Definitions » Capex-to-Revenue

Maven Brands (XCNQ:MJ) Capex-to-Revenue : 0.00 (As of Dec. 2022)


View and export this data going back to 2015. Start your Free Trial

What is Maven Brands Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Maven Brands's Capital Expenditure for the three months ended in Dec. 2022 was C$0.00 Mil. Its Revenue for the three months ended in Dec. 2022 was C$0.00 Mil.

GuruFocus do not calculate Capex-to-Revenue if the revenue is negative.


Maven Brands Capex-to-Revenue Historical Data

The historical data trend for Maven Brands's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maven Brands Capex-to-Revenue Chart

Maven Brands Annual Data
Trend Dec14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only 2.87 - - - -

Maven Brands Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Maven Brands's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Maven Brands's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maven Brands's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Maven Brands's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Maven Brands's Capex-to-Revenue falls into.



Maven Brands Capex-to-Revenue Calculation

Maven Brands's Capex-to-Revenue for the fiscal year that ended in Mar. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.163) / 0
=N/A

Maven Brands's Capex-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Maven Brands  (XCNQ:MJ) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Maven Brands Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Maven Brands's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Maven Brands (XCNQ:MJ) Business Description

Traded in Other Exchanges
N/A
Address
100 Kalamalka Lake Road, Unit 32, Vernon, BC, CAN, V1T 9G1
Maven Brands Inc is a licensed producer of medicinal cannabis for the Canadian market under Canada's Marihuana for Medical Purposes Regulations program administered by Health Canada. The company is launching an innovative services program to provide seed-to-shelf solutions for cannabis micro-cultivators and small-scale producers across Canada. Its services will be designed to support craft growers on a path to the regulated market and will operate from the True Leaf Campus facility located in Lumby, British Columbia.